Search by Drug Name or NDC

    NDC 00597-0192-61 Striverdi Respimat 2.5 ug/1 Details

    Striverdi Respimat 2.5 ug/1

    Striverdi Respimat is a RESPIRATORY (INHALATION) SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is OLODATEROL HYDROCHLORIDE.

    Product Information

    NDC 00597-0192
    Product ID 0597-0192_95406558-30c2-422e-a10a-c1b3d78ff40a
    Associated GPIs 44201052203410
    GCN Sequence Number 072077
    GCN Sequence Number Description olodaterol HCl MIST INHAL 2.5 MCG INHALATION
    HIC3 B6Z
    HIC3 Description BETA-ADRENERGIC AGENTS, INHALED, ULTRA-LONG ACTING
    GCN 36174
    HICL Sequence Number 040969
    HICL Sequence Number Description OLODATEROL HCL
    Brand/Generic Brand
    Proprietary Name Striverdi Respimat
    Proprietary Name Suffix n/a
    Non-Proprietary Name olodaterol respimat inhalation spray
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SPRAY, METERED
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 2.5
    Active Ingredient Units ug/1
    Substance Name OLODATEROL HYDROCHLORIDE
    Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
    Pharmaceutical Class Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA203108
    Listing Certified Through 2024-12-31

    Package

    NDC 00597-0192-61 (00597019261)

    NDC Package Code 0597-0192-61
    Billing NDC 00597019261
    Package 1 CARTRIDGE in 1 CARTON (0597-0192-61) / 60 SPRAY, METERED in 1 CARTRIDGE
    Marketing Start Date 2014-08-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 62.6821
    Pricing Unit GM
    Effective Date 2024-01-01
    NDC Description STRIVERDI RESPIMAT INHAL SPRAY
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis